PLUS THERAPEUTICS (PSTV) Financials

$3.84

$0.07 (1.80%)

As on 07-Aug-2026 09:30EDT

Market cap

$27 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

0.2

P/B Ratio

3.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	4.20	5.21	5.82	4.91	0.22	--
Cost of Revenue	0.40	0.45	0.85	9.69	0.71	0.07
Gross Profit	2.59	4.77	4.97	-4.78	-0.49	-0.07
Operating Expenses	30.32	20.07	19.67	8.54	19.22	12.43
Operating Profit (EBIT)	-26.40	-15.30	-14.70	-13.32	-19.71	-12.49
Other Income	--	--	--	--	--	--
Profit before Tax	-26.09	-22.39	-12.98	-13.32	-20.28	-13.40
Provision for Tax	--	--	--	--	0.56	0.93
Profit after Tax (Net Income)	-26.09	-22.39	-12.98	-13.32	-20.28	-13.40
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-20.28	-13.40

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	5.46	4.00	-8.95	-1.35	6.45	10.84
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.02	0.03	2.01	5.57	5.28
Current Liabilities	8.57	12.31	15.55	10.73	11.85	5.87
Total Liabilities	22.60	16.33	6.63	11.39	23.87	21.98

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	2.26	1.16	1.37	1.55	2.05	2.26
Current Assets	11.77	15.17	5.26	9.83	21.82	19.72
Total Assets	25.80	16.33	6.63	11.39	23.87	21.98
Total Debt*	0.04	0.82	3.37	4.18	5.76	6.99
Net Current Assets	--	2.86	-10.29	-0.89	9.97	13.85

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-20.78	-10.55	-12.85	-12.97	-10.28
Cash Flow from Investing Activities	--	-0.85	-4.11	-0.16	-0.76	-0.08
Cash from Financing Activities	--	30.31	6.19	3.45	13.45	20.42
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-4.21	-7.19	-2.20	-2.96	-11.58	-16.63
Cash EPS ($)	--	-7.05	-2.08	-2.82	-11.23	-16.14
Adjusted Book Value ($)	--	1.28	--	--	3.68	13.45
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-6.68	-1.79	-2.86	-7.41	-12.76
Free Cash Flow per Share ($)	--	-6.70	-1.81	-2.89	-7.84	-12.93

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	5,852.55	944.20	-177.16	-135.04	-96.20
ROE (%)	-551.60	903.94	252.07	-522.50	-234.65	-193.25
ROA (%)	-120.04	-195.02	-144.03	-75.54	-88.44	-78.62
EBIT Margin (%)	-539.71	-360.20	-158.89	-263.00	-8,733.93	--
Net Margin (%)	-620.70	-429.43	-222.84	-271.04	-9,051.34	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-20.95	-0.10	0.19	20.93	--	-1.00
EBIT Growth (%)	-49.73	-102.91	28.38	33.96	-56.93	-41.62
Net Profit Growth (%)	-37.11	-72.49	2.54	34.32	-51.32	-62.59
EPS Growth (%)	-91.77	-2.27	0.26	0.74	0.30	-7.93
Book Value Growth (%)	5,460.27	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	0.18	-0.07	-0.52	-0.59	-0.03	-0.06
Price / Book Value	3.75	0.40	-0.76	-5.84	0.09	0.08
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	29.14	0.58	-0.78	-0.28	0.63	0.88
Close Price ($)	4.37	12.81	28.75	43.75	118.88	393.75
High Price ($)	23.43	57.75	66.76	180.00	810.00	2,032.50
Low Price ($)	2.90	4.09	23.13	24.25	108.75	371.78
Market Cap ($ Cr)	26.64	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.21	-0.38	-3.10	0.89	0.65
Short term debt to equity ratio	0.01	0.20	-0.37	-3.04	0.28	0.16
Current Ratio	1.37	1.23	0.34	0.92	1.84	3.36
Quick Ratio	1.37	--	--	--	--	3.36
Interest Coverage	-7.46	-5.20	-2.48	-32.71	-27.52	-13.38

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	41.90	--	9.80	--	--	--
Asset Turnover	0.19	0.45	0.65	0.28	0.01	--
Receivable days	--	40.01	35.81	--	11.41	--
Inventory Days	--	--	--	--	-3.59	-182.63
Payable days	--	5,232.51	3,050.61	247.31	2,815.04	9,407.95
Cash Conversion Cycle	--	--	--	--	-2,807.22	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.